CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Common Stock	Additional Paid-In Capital	Retained Earnings	Treasury Stock	Accumulated Other Comprehensive Loss	Total
BEGINNING BALANCE at Jun. 30, 2023	$ 119	$ 218,260	$ 270,720	$ (21,116)	$ (21,925)	$ 446,058
Net income			36,652			36,652
Change in unrealized loss on available for sale securities					2,874	2,874
Dividends paid on common stock			(7,145)			(7,145)
Stock option expense		283				283
Stock grant expense		657				657
Stock options exercised		391				391
Common stock issued	1					1
Treasury stock purchased				(187)		(187)
ENDING BALANCE at Mar. 31, 2024	120	219,591	300,227	(21,303)	(19,051)	479,584
BEGINNING BALANCE at Dec. 31, 2023	119	218,675	291,304	(21,116)	(18,800)	470,182
Net income			11,307			11,307
Change in unrealized loss on available for sale securities					(251)	(251)
Dividends paid on common stock			(2,384)			(2,384)
Stock option expense		84				84
Stock grant expense		657				657
Stock options exercised		175				175
Common stock issued	1					1
Treasury stock purchased				(187)		(187)
ENDING BALANCE at Mar. 31, 2024	120	219,591	300,227	(21,303)	(19,051)	479,584
BEGINNING BALANCE at Jun. 30, 2024	120	219,680	311,376	(24,973)	(17,455)	488,748
Net income			42,792			42,792
Change in unrealized loss on available for sale securities					3,463	3,463
Dividends paid on common stock			(7,783)			(7,783)
Stock option expense		272				272
Stock grant expense		1,298				1,298
ENDING BALANCE at Mar. 31, 2025	120	221,250	346,385	(24,973)	(13,992)	528,790
BEGINNING BALANCE at Dec. 31, 2024	120	220,358	333,297	(24,973)	(16,431)	512,371
Net income			15,683			15,683
Change in unrealized loss on available for sale securities					2,439	2,439
Dividends paid on common stock			(2,595)			(2,595)
Stock option expense		93				93
Stock grant expense		799				799
ENDING BALANCE at Mar. 31, 2025	$ 120	$ 221,250	$ 346,385	$ (24,973)	$ (13,992)	$ 528,790